A review on the treatment of acne vulgaris

International Journal of Clinical Practice

Volumn 60, Issue 1, 2006, Pages 64-72

  Layton, Alison M ^a  

^a HARROGATE AND DISTRICT NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acne therapy; Acne vulgaris; Antibiotic resistance; Atypical acne

Indexed keywords

ADAPALENE; AMPICILLIN; ANTIBIOTIC AGENT; AZELAIC ACID; BENZOYL PEROXIDE; CLINDAMYCIN; CLOBETASOL PROPIONATE; CYPROTERONE ACETATE; DESOGESTREL; DIANE; DOXYCYCLINE; ERYTHROMYCIN; ISOTRETINOIN; LEVONORGESTREL; LOCAL ANESTHETIC AGENT; LYMECYCLINE; MINOCYCLINE; ORAL CONTRACEPTIVE AGENT; OXYTETRACYCLINE; PREDNISOLONE; QUINOLINOL DERIVATIVE; RETINOIC ACID; RETINOID DERIVATIVE; SPIRONOLACTONE; STEROID; TETRACYCLINE; TRIAMCINOLONE ACETONIDE; TRIMETHOPRIM; UNINDEXED DRUG; ZINC; ANTIINFECTIVE AGENT; DERMATOLOGICAL AGENT;

ACNE CONGLOBATA; ACNE FULMINANS; ACNE VULGARIS; AGRANULOCYTOSIS; AUTOIMMUNE HEPATITIS; BODY DYSMORPHIC DISORDER; BRAIN PSEUDOTUMOR; CLINICAL TRIAL; COMEDO; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DRUG ABSORPTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG POTENTIATION; FOLLICULITIS; GASTROINTESTINAL SYMPTOM; HEADACHE; HORMONAL THERAPY; HUMAN; IRRITANT DERMATITIS; LIVER TOXICITY; LUPUS LIKE SYNDROME; MEDICAL DECISION MAKING; MENTAL DISEASE; MOOD DISORDER; NAUSEA; NEPHROTOXICITY; NONHUMAN; ONYCHOLYSIS; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PHOTOTHERAPY; PIGMENT DISORDER; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PSYCHOSOCIAL DISORDER; PYODERMA; REVIEW; SCAR FORMATION; SKIN DEFECT; SKIN DISEASE; SKIN INFLAMMATION; SKIN IRRITATION; SKIN NODULE; SUICIDE; THROMBOEMBOLISM; TREATMENT PLANNING; DRUG RESISTANCE; PHYSIOTHERAPY; SCAR; TOPICAL DRUG ADMINISTRATION;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; CICATRIX; DERMATOLOGIC AGENTS; DRUG RESISTANCE; HUMANS; PHYSICAL THERAPY MODALITIES;

EID: 33644843906     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2005.00695.x     Document Type: Review

References (61)

1. Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol 1994; 19: 303-8.
2. Rubinov DR. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987; 17: 25-32.
3. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139: 846-50.
4. Jowett S, Ryan T. Skin disease and handicap: An analysis of the impact of skin conditions. Soc Sci Med 1985; 20: 425-9.
5. Finlay AY, Khan GK. Dermatology Life Quality Index (OLQI). A simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-6.
6. Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol 1992; 17: 1-3.
7. Layton AM, Seukeran DC, Cunliffe WJ. Scarred for life. Dermatology 1997; 195: 15-21.
8. Ozolins M, Eady EA, Avery A. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facila acne vulgaris in the community: Randomised controlled trial. Lancet 2004; 364: 2188-95.
9. Christophers E, Wolfe HH. Effect of vitamin A acid on skin: In vivo and in vitro studies. Acta Derm Venereol Suppl (Stockh) 1975; 74: 42-53.
10. Leyden J. Rational therapy for acne vulgaris: An update on topical treatment. J Am Acad Dermatol 1986; 15: 970-15.
11. Shalita AR, Weiss JS, Chalker DK et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: A multicentre trial. J Am Acad Dermatol 1999; 34: 482-5.
12. Schefer H. Penetration and percutaneous absorption of topical retinoids. A Review. Skin Pharmacol 1993; 6: 17-23.
13. Fulton JE, Farzad-Batshandeth A. Studies on the mechanism of action of topical benzoyl peroxide in acne vulgaris. J Cutan Pathol 1974; 1: 191-200.
14. Holland KT, Bojar RA. Antimicrobial effects of azelaic acid. J Dermatol treat 1993; 4: S8-11.
15. Mayer De Dilva A, Gollnick H, Detmar M et al. Effects of azelaic acid on sebaceous glands, sebum excretion rate and keratinisation patterns in human skin. Acta Derm Venereol 1979; 143: 20-30.
16. Eady EA, Hope JH, Jones DN et al. Topical antibiotics for the treatment of acne: A critical evaluation of the literature on their clinical benefit and comparative efficacy. J Dermatol Treat 1990; 1: 215-26.
17. Thomas DR, Raimer S, Smith BE. Comparison of topical erythromycin 1.5% solution vs topical clindamycin phosphate 1% solution in the treatment of acne vulgaris. Cutis 1982; 29: 624-532.
18. Eady EA, Jones CE, Tipper JL et al. Antibiotic resistant propionibacteria in acne. Need for policy for antibiotic usage. BMJ 1993; 306: 555-6.
19. Fenchi CL, Allen BS, Chalker DK et al. Topical erythromycin with zinc in acne. A double blind controlled study. J Am Acad Dermatol 1980; 3: 483-91.
20. Chalker DK, Shalita AR, Smith JG et al. A double blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris. J Am Acad Dermatol 1983; 9: 933-6.
21. Farmery MR, Jones CE, Eady CA et al. In vitro activity of azelaic acid, benzoyl peroxide and zinc acetate against antibiotic resistant propionibacteria from acne patients. J Dermatol Treat 1994; 5: 63-5.
22. Eady EA, Farmery MR, Ross JI et al. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic sensitive and resistant skin bacteria from acne patients. Br J Dermatol 1994; 131: 331-6.
23. Rietschel R, Duncan BS. Clindamycin phosphate used in combination with tretinoin in the treatment of acne. Int J Dermatol 1983; 22: 41-3.
24. Mills OH, Kligman AM. Treatment of acne vulgaris with topically applied erythromycin and tretinoin. Acta Derm Venereol Suppl (Stockh) 1978; 58: 555-7.
25. Tucker SB, Tousend R, Cochrane R et al. Comparison of topical clindamycin phosphate, benzoyl peroxide and a combination of the two in the treatment of acne vulgaris. Br J Dermatol 1984; 1001: 487-92.
26. Hurwitz S. Combined effect of vitamin A acid and benzoyl peroxide in the treatment of acne. Cutis 1976; 17: 585-90.
27. Marples RR, Kligman AM. Ecological effects of oral antibiotics on the microflora of human skin. Arch Dermatol 1971; 103: 143-53.
28. Esterley NB, Furcy NL, Fiaragcan LE. The effect of antimicrobial agents on leukocyte chemotaxis. J Invest Dermatol 1979; 70: 51-5.
29. Cunliffe WJ, Cleydon AD, Gould D et al. Acne vulgaris -its aetiology and treatment. A Review. Clin Exp Dermatol 1981; 6: 461-9.
30. Dreno B, Bettoli V, Ochsendorf F, Layton A, Mobacken H, Degreef H. European recommendations on the use of oral antibiotics for acne. Eur J Dermatol 2004; 14: 391-9.
31. Eady EA, Cove JH, Hollan KT, Cunliffe WJ. Erythromycin resistant propionibacteria in antibiotic treated acne patients associated with therapeutic failure. Br J Dermatol 1989; 121: 51-7.
32. Knaggs HE, Layton AM, Cunliffe WJ. The role of oral minocycline and erythromycin in tetracycline resistant acne - a retrospective study and a review. J Dermatol Treat 1993; 4: 53-6.
33. Garner SE, Eady EA, Propescu C et al. Minocycline for acne vulgaris: efficacy and safety (Cochraine Review). In: The Cochraine Library Issue 4. Oxford: Update Software, 2001.
34. Bottomley WW, Cunliffe WJ. Oral trimethoprim as a third line antibiotic treatment in the management of acne vulgaris. Dermatology 1993; 187: 193-6.
35. Eady EA, Jones CE, Gardner KJ et al. Tetracycline resistant propionibacteria from acne patients are cross-resistant to doxycycline but sensitive to minocycline. Br J Dermatol 1993; 128: 556-60.
36. Coates P, Adams CA, Cunliffe WJ et al. Does oral isotretinoin prevent Propionibacterium acnes resistance? Dermatology 1997; 195 (Suppl. 1): 4-9.
37. Coates P, Vyakrnam S, Ravenscrof JC et al. Efficacy of oral isotretinoin in the control of skin and nasal colonisation by antibiotic resistant propionibacteria. Br J Dermatol 2002; 146: 840-8.
38. Hanstead B, Reymann F. Cyproterone acetate in the treatment of acne vulgaris in adult females. Dermatologica 1982; 164: 117-26.
39. Greenwood R, Brummitt L, Burke B et al. Acne: A double blind clinical and laboratory trial of tetracycline, oestrogen, cyproterone acetate and combined treatment. BMJ 1985; 291: 1231-5.
40. Aurowojolu AO, Gallo MF, Grimes DA, Garner SE. Combined oral contraceptive pills for the treatment of acne. Cochrane database syst rev 2004; 3: CD004425.
41. Burke BM, Cunliffe WJ. Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia. Br J Dermatol 1984: 124-6.
42. Cunliffe WJ. Treatment of acne. In: Marks R., ed. Acne and Acne Related Disorders. London: M Dunitz, 1989: 266 -76.
43. Layton AM, Knaggs HE, Taylor J et al. Isotretinoin for acne vulgaris - 10 years later. A safe and successful treatment. Br J Dermatol 1993; 129: 292-6.
44. Cunliffe WJ, Van De Kerkhof PCM, Caputo R et al. Roaccutane treatment guidelines, results of an international survey. Dermatology 1997; 194: 351-7.
45. Clark SM, Cunliffe WJ. Acne flare and isotretinoin - incidence and treatment. Br J Dermatol 1995; 133: 26.
46. Pepall LM, Cosgrove MP, Cunliffe WJ. Ablation of whiteheads by cautery under topical anaesthetic. Br J Dermatol 1991; 125: 256-9.
47. Karvone S. Acne fulminans: Report of clinical findings and treatment of 24 patients. J Am Acad Dermatol 1993; 28: 572-9.
48. Jacobs DG, Deutsch NL, Brewer M. Suicide, depression and isotretinoin. Is there a causal link. J Am Acad Dermatol 2001; 45: S168-75.
49. Orentreich N, Durr NP, Frank SB, eds. Acne, New York: Yorke medical books, 1979.
50. Charakida A, Seaton ED, Charakida M. Phototherapy in the treatment of acne - what is its role? Am J Clin Dermatol 2004; 5: 211-6.
51. Pollock B, Turner D, Stringer MR. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: A study of clinical efficacy and mechanism of action. Br J Dermatol 2004; 151: 616-22.
52. Papageorgiou P, Katsambar A, Chu A. Phototherapy with blue (415 nm) and red (600 nm) light in the treatment of acne vulgaris. Br J Dermatol 2000; 142: 973-8.
53. Leyden JJ, Marples RR, Mills OK. Gram negative folliculitis - a complication of antibiotic therapy in acne vulgaris. Br J Dermatol 1973; 88: 533-8.
54. James WD, Leyden JJ. Treatment of gram negative folliculitis with isotretinoin. Positive clinical and microbiological response. J Am Acad Dermatol 1985; 12: 319-24.
55. Sneddon J, Sneddon I. Acne excoriée: A protective device. Clin Exp Dermatol 1983; 8: 65-8.
56. Kent A, Drummond LM. Acne excoriée - a case report using habit reversal. Clin Exp Dermatol 1989; 14: 163-4.
57. Cotterill JA. Dermatological non-disease. Dermatol Clin 1996; 14: 439-45.
58. Karvone SL, Rasane L, Cunliffe WJ et al. Delayed hypersensitivity to Propionibacterium acnes in patients with severe nodular acne and acne fulminans. Dermatology 1994; 189: 344-9.
59. Massa MC, Su WP. Pyoderma faciale: A clinical study of twenty-nine patients. J Am Acad Dermatol 1982; 6: 84-91.
60. Kligman AM, Mills OH. Acne cosmetica. Arch Dermatol 1970; 10: 843-50.
61. Plewig G, Fulton JE, Kligman AM. Pomade acne. Arch Dermatol 1970; 101: 580.